Regulatory Affairs

EMA Seeks to Increase Quality of Immunogenicity Studies

A European Medicines Agency working group is recommending revisions to a guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins to account for differences between large complex and small, simple-structured proteins and other critical issues. Read More